Potentia Pharmaceuticals aims to cure age-related macular degeneration through innovative anti-inflammatory treatments.
Potentia is an early stage biotechnology company focused on developing innovative therapeutics, primarily in the area of age-related macular degeneration and other inflammatory ocular diseases. Potentia assembles its pipeline of anti-inflammatory products through a combination o...
MediQuest Therapeutics, Inc. ("MediQuest") is a development-stage, privately-held biopharmaceutical company. MediQuest's mission is to become the premier healthcare company targeting inflammatory/infectious skin diseases and conditions. The initial product focus has emphasized the use of its proprietary Topical Amphi-Matrix™ delivery system specifically designed to transport agen...
MaxCyte Inc. is a clinical stage company developing cell-based therapeutics primarily in the areas of oncology and regenerative medicine. MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical candidates to treat a variety of diseases with unmet needs. The company also offers its unparalleled, customizab...
Cima NanoTech is an advanced materials company specializing in nanomaterials for the biomedical and electronics industries. The company's commercial scale nanomaterial production and advanced formulation capability have resulted in the development of innovative technologies, including inks for use in printed electronics and other applications, as well as self-assembled transparent conductive...
enGene’s technology, Gut Endocrine-cell Modification System (GEMSTM), utilizes the therapeutic protein production capacity of existing, normal, healthy cells in a small, targeted area of the duodenum by delivering a gene construct in a novel non-viral vector. For GEMSTM –Insulin, this means enabling the patients’ own cells to produce insulin in a regulated, meal-dependant...
JADO is the first mover in raft intervention therapeutics, a paradigm shift with relevance to viral and bacterial disease, allergy, Alzheimer's disease and cancer. The company's Raft Intervention Technology® provides insight into diverse pathological mechanisms and drives the design of novel drugs. The company has generated a pipeline of small molecule drug candidates, enabled by the expertise...
Correlogic Systems, Inc. has pioneered the use of pattern recognition technologies for the development of proteomic, metabolomic and genomic based clinical prognostic and clinical diagnostic tests. The company has applied its proprietary software and sample preparation technologies to a wide range of high throughput bioassay platforms, including mass spectrometry, nuclear magnetic resonance spec...
FASgen was formed in 1999 to access both therapeutic and diagnostic technologies based on the critical role played by fatty acid biosynthesis in health and disease. FASgen holds exclusive licenses from Johns Hopkins University (JHU) to extensive patent estate as well as all subsequent improvements for therapeutic and diagnostic applications of the discoveries by the company's founders and their co...
Envisionier Medical Technologies is developing portable, handheld endoscopic technologies. Envisionier's first product, the Endogo camera, is the world's first battery operated, portable, light-weight, hand-held endoscopic camera with integrated viewing and archiving capabilities. The Endogo is targeting office-based physicians in the ENT, OB/GYN and Urology areas. This unique device offers physic...
Cytox is developing products for Alzheimer’s disease (AD) diagnosis and treatment based on the cell division cycle theory of AD pathogenesis. Cytox products address the unmet needs for early diagnosis–before irreversible brain degeneration, and eventually symptoms, occur–and for new treatment strategies. Cytox's cellular (lymphocyte) and genetic assays are used sequen...
Potentia Pharmaceuticals aims to cure age-related macular degeneration through innovative anti-inflammatory treatments.
Potentia is an early stage biotechnology company focused on developing innovative therapeutics, primarily in the area of age-related macular degeneration and other inflammatory ocular diseases. Potentia assembles its pipeline of anti-inflammatory products through a combination o...
